References
- Hoksch B, Fahrner R, Fahrner R, Alexander Schmid R. Procalcitonin and brain natriuretic peptide as parameters in the postoperative course of patients with major pulmonary resection. Interact Cardiovasc Thorac Surg. 2007;6(2):155–159. doi:https://doi.org/10.1510/icvts.2006.143073.
- Franke A, Lante W, Kupser S, Becker HP, Weinhold C, Markewitz A. Procalcitonin levels after different types of conventional thoracic surgery. Thorac Cardiovasc Surg. 2008;56(1):46–50. doi:https://doi.org/10.1055/s-2007-989250.
- Falcoz P, Laluc F, Toubin M, et al. Usefulness of procalcitonin in the early detection of infection after thoracic surgery. Eur J Cardiothorac Surg. 2005;27(6):1074–1078. doi:https://doi.org/10.1016/j.ejcts.2005.02.022.
- Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intens Care Med. 1998;24(7):680–684. doi:https://doi.org/10.1007/s001340050644.
- Carboni GL, Fahrner R, Gazdhar A, Printzen G, Schmid RA, Hoksch B. Comparison of procalcitonin and CrP in the postoperative course after lung decortication. Eur J Cardiothorac Surg. 2008;33(5):777–780. doi:https://doi.org/10.1016/j.ejcts.2008.02.013.
- Bréchot N, Hékimian G, Chastre J, Luyt CE. Procalcitonin to guide antibiotic therapy in the ICU. Int J Antimicrob Agents. 2015;46(Suppl 1):S19–S24. doi:https://doi.org/10.1016/j.ijantimicag.2015.10.012.
- Assink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients-calculated sample size: 1816 patients. BMC Infect Dis. 2013;13:178. doi:https://doi.org/10.1186/1471-2334-13-178.
- Tonkin-Crine SK, Tan PS, van Hecke O, et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev. 2017;9:CD012252. doi:https://doi.org/10.1002/14651858.CD012252.pub2.
- Doğan C, Bilaçeroğlu S, Çirak AK, Özsöz A, Özbek D. [Diagnostic value of pleural fluid and serum procalcitonin levels in the diagnosis of parapneumonic pleural effusion. Tuberk Toraks. 2013;61(2):103–109. doi:https://doi.org/10.5578/tt.5334.
- Zou MX, Zhou RR, Wu WJ, Zhang NJ, Liu WE, Fan XG. The use of pleural fluid procalcitonin and C-reactive protein in the diagnosis of parapneumonic pleural effusions: a systemic review and meta-analysis. Am J Emerg Med. 2012;30(9):1907–1914. doi:https://doi.org/10.1016/j.ajem.2012.04.004.
- Felix F, Pierre F, Benjamin K, Michele S, Cameron W, Brunelli A. The Society of Thoracic Surgeons and The European Society of Thoracic Surgeons General Thoracic Surgery Databases: joint standardization of variable definitions and terminology. Ann Thorac Surg. 2015;99(1):368–376. doi:https://doi.org/10.1016/j.athoracsur.2014.05.104.
- Lin MC, Chen YC, Wu JT, Ko YC, Wang CC. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions. Chest. 2009;136(1):205–211. doi:https://doi.org/10.1378/chest.08-1134.
- Wang CY, Hsiao YC, Jerng JS, Ho CC, et al. Diagnostic value of procalcitonin in pleural effusions. Eur J Clin Microbiol Infect Dis. 2011;30(3):313–318. doi:https://doi.org/10.1007/s10096-010-1082-0.
- Lee SH, Lee EJ, Min KH, et al. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Clin Biochem. 2013;46(15):1484–1488. doi:https://doi.org/10.1016/j.clinbiochem.2013.03.018.
- Enguix A, Rey C, Concha A, Medina A, Coto D, Diéguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intens Care Med. 2001;27(1):211–215. doi:https://doi.org/10.1007/s001340000709.
- Fink-Neuboeck N, Lindenmann J, Bajric S, et al. Clinical impact of interleukin 6 as a predictive biomarker in the early diagnosis of postoperative systemic inflammatory response syndrome after major thoracic surgery: a prospective clinical trial. Surgery. 2016;160(2):443–453. doi:https://doi.org/10.1016/j.surg.2016.04.004.